Literature DB >> 8037493

Predicting outcome in current clinic attenders: a biased view.

E M Hay1, P Croft.   

Abstract

Mesh：

Year:  1994        PMID： 8037493      PMCID： PMC1005349          DOI： 10.1136/ard.53.6.357

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  The importance of incidence registries for connective tissue diseases.

Authors:  D J McCarty; C K Kwoh; R E LaPorte
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

2.  The natural history of ankylosing spondylitis: is the disease really changing?

Authors:  J F Fries; G Singh; D A Bloch; A Calin
Journal:  J Rheumatol       Date:  1989-07       Impact factor: 4.666

3.  Pitfalls in assessment of prognosis. Weak study designs are liable to bias.

Authors:  S M van der Linden; P Tugwell
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

4.  Ankylosing spondylitis--an analytical review of 1500 patients: the changing pattern of disease.

Authors:  A Calin; J Elswood; S Rigg; S M Skevington
Journal:  J Rheumatol       Date:  1988-08       Impact factor: 4.666

5.  Environmental factors predicting nephritis in systemic lupus erythematosus.

Authors:  T McAlindon; L Giannotta; N Taub; D D'Cruz; G Hughes
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103
  5 in total
  2 in total

1.  A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets.

Authors:  S Jacobsen; J Petersen; S Ullman; P Junker; A Voss; J M Rasmussen; U Tarp; L H Poulsen; G van Overeem Hansen; B Skaarup; T M Hansen; J Pødenphant; P Halberg
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

2.  Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus.

Authors:  N D Hopkinson; C Jenkinson; K R Muir; M Doherty; R J Powell
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.